Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-30

Clinical Trial Update: Maraviroc and NeuroAIDS Pathogenesis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on maraviroc for AIDS dementia complex (neuroAIDS pathogenesis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Maraviroc (maraviroc)

Snippet

Sponsor: University of Hawaii | Conditions: AIDS Dementia Complex | Phase 2, Phase 3 | Status: COMPLETED